All news from Anaesthesiology

Anti-inflammatory Drug Reduces Cardiovascular Risks in a Subset of Population

A new study published in the Journal of the American College of Cardiology (JACC) found that anti-inflammatory therapy canakinumab substantially reduced cardiovascular event rates in high-risk atherosclerotic patients with chronic kidney disease (CKD) or those with pre-diabetes/diagnosed type 2 diabetes, while having neither clinically meaningful benefits nor substantive harms with respect to adverse renal events or glucose control.

 

Tickborne Parasite Detected in Human Plasma and Whole Blood Samples

The U.S. Food and Drug Administration approved the Imugen Babesia microti Arrayed Fluorescent Immunoassay (AFIA), for the detection of antibodies to Babesia microti (B. microti) in human plasma samples, and the Imugen Babesia microti Nucleic Acid Test (NAT), for the detection of B. microti DNA in human whole blood samples.

These tests are intended to be used as donor screening tests on samples from individual human donors, including volunteer donors of whole blood and blood components, as well as living organ and tissue donors.

Pulmonary Fibrosis can be Reduced by Restoring Lipid Synthesis

A new study, published in American Journal of Respiratory Cell and Molecular Biology (AJRCMB), suggest that ability of the body to produce lipids in the lungs could be enhanced to prevent the progression of pulmonary fibrosis, an ongoing process of scarring that leaves patients chronically short of breath, can progress in severity until the only course of treatment is lung transplant.